Skip to main content
BMC Public Health logoLink to BMC Public Health
. 2025 May 27;25:1961. doi: 10.1186/s12889-025-22876-0

Barriers and facilitators of pap-smear test uptake in Asia: a systematic review

Aisa Maleki 1, Bahman Ahadinezhad 2, Ahad Alizadeh 2, Omid Khosravizadeh 2,
PMCID: PMC12107982  PMID: 40426094

Abstract

Background

In addition to the establishment of screening procedures, it is important to identify the barriers and facilitators for promoting preventive behavior. Many studies have been conducted in the field of investigating the factors affecting Pap smear test uptake and the barriers related to it. However, a systematic approach is still needed. Therefore, this present study was conducted with the aim of systematically reviewing the barriers and facilitators of Pap smear test uptake in Asia.

Methods

To collect the data, searches were performed in PubMed, WOS, ProQuest, Scopus and Cochrane databases from January 1, 2018 to January 15, 2025. Two people separately and independently evaluated the quality of the studies by Newcastle-Ottawa Scale. To conceptualize influential factors, barriers and facilitators of Pap-smear test uptake among Asian women, a theoretical thematic analysis was applied.

Results

A search yielded 4057 records, of which 44 documents discussing the determinants, barriers, and facilitators of Pap smear uptake were included in the review. There were economic, social, awareness, test and provider characteristics, and lifestyle and health behaviors dimensions in both categories of barriers and facilitators. In addition, two religious and psychological dimensions were included in the barriers category. In total, 55 components representing barriers and 51 components representing facilitators were identified.

Conclusion

To improve Pap smear uptake, implement financial assistance and comprehensive insurance coverage. Enhance community engagement through outreach and support groups, provide counseling, and create positive messaging. Increase accessibility with mobile clinics, flexible hours, and train providers. Promote health education and offer incentives to motivate women to participate in screenings.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12889-025-22876-0.

Keywords: Pap-smear test, Cervical cancer screening, Barriers, Facilitators, Systematic review

Introduction

Cervical cancer is the second most common cancer in the world and is the second cause of death among women [1]. Countries with a low Human Development Index (HDI) have the highest incidence and mortality rates of cervical cancer [2]. Five-year survival of this type of cancer in countries with low HDI is about 40% lower than in countries with high HDI [3]. Nearly 85% of deaths due to this type of cancer are imposed on low- and middle-income countries, and these countries endure the greatest burden [46].

Six hundred sixty-two thousand three hundred one new cases and 348,874 deaths from cervical cancer were documented globally in 2022 [7]. Recent estimates indicate that cervical cancer will likely cause 600,000 new cases and 300,000 deaths yearly [4]. It’s predicted that new cases arise to 908,612 up to 2045 [7, 8]. Asia, the most populous continent (2,273,786,930), had the highest number of new cases in 2022 (397,082) and predictions for 2045 (543,703) [8]. Globocan stated in 2020 that the number of new cases of cervical cancer in countries with very high HDI was 98,675, with high HDI 240,400, with medium HDI 182,866, and with low HDI 81,922 [9]. According to this report, deaths from this cancer in countries with very high HDI was 42,920, with high HDI 129,444, with moderate HDI 113,149, and with low HDI 56,167 [9].

This cancer is often preventable [5]. The five-year survival rate of this cancer in case of early diagnosis is about 70% higher than late diagnosis or metastasis [10]. Vaccination against HPV and secondary preventive measures (types of screening) are preventive ways to deal with this type of cancer [1, 10].

According to the statements of the World Health Organization, a non-communicable disease control program should be implemented by relying on a surveillance and monitoring system that includes reliable and quality population data [1]. In the last 50 years, the incidence and death caused by this type of cancer have decreased in all countries that have a composed screening program and have implemented it effectively [11].

In 1970, the traditional screening method for this type of cancer (Cytology test or Pap-smear test) was proposed and recommended for the first time [12]. For individuals aged 23 to 50 years, this test should be conducted every three years, while for those aged 51 to 60 years, it should be performed every five years [13]. Many experimental studies have confirmed the effectiveness of the Pap smear test in reducing the incidence and death of cervical cancer [12]. In the last 50 years, the regular program of Pap smear tests has decreased the incidence and death of this cancer to one-fifth [14]. Regular, timely, and high-quality screening in countries with high HDI has made this program successful [5]. At the same time, screening depends on factors such as socioeconomic level, education level, place of residence, race, sexual orientation, and insurance [15]. These factors may appear as barriers or incentives to Pap smear test uptake.

The World Health Organization has identified the cervical cancer prevention program as a key priority. On the other hand, in addition to the establishment of screening procedures, it is important to identify the barriers and facilitators for promoting preventive behavior. By identifying and removing barriers and facilitating screening, people can be led to prevent the incidence or deterioration of cancer. Many studies have been conducted in the field of investigating the factors affecting Pap smear test uptake and the barriers related to it. However, there is a need for a more rigorous search to cover gaps in previous studies and provide more comprehensive and up-to-date results. Therefore, this present study was conducted with the aim of systematically reviewing the barriers and facilitators of Pap smear test uptake in Asia. The specific study of Asia is important because it accounts for about 60% of the world's population and more than 50% of new cases of cervical cancer. Focusing on Asia for a systematic review of barriers and facilitators of pap-smear test uptake is crucial due to diverse cultural norms, varying healthcare systems, and significant cervical cancer rates in the region. Economic disparities and differences in health education impact screening access and awareness. Understanding region-specific challenges can inform targeted interventions and improve preventive healthcare outcomes for women across diverse Asian contexts.

Materials and methods

Search strategy

This research was accomplished based on PRISMA guidelines [16]. Searches were performed in PubMed, WOS, ProQuest, Scopus and Cochrane databases. The keywords used in the search are: Pap smear, Pap test, Papanicolaou test, Papanicolaou smear, Vaginal smear, Cervical cancer, Cervix cancer, Cervical cancer screening, Cervix cancer screening, Cervical cancer, Cervix cancer, Determin*, Factor, Barrier, obstacle, Facilitator. Sample search strategies according to databases are presented in Table 1.

Table 1.

Search strategies

Data base Search strategy #
PubMed ("pap smear"[Title/Abstract] OR"Pap test"[Title/Abstract] OR"Papanicolaou test"[Title/Abstract] OR"Papanicolaou smear"[Title/Abstract] OR"Vaginal smear"[Title/Abstract] OR"Cervical cancer screening"[Title/Abstract] OR"Cervix cancer screening"[Title/Abstract]) AND (Determinant[Title/Abstract] OR Factor[Title/Abstract] OR Barrier[Title/Abstract] OR obstacle [Title/Abstract] OR Facilitator[Title/Abstract]) Filters: 2018–2025 1975
Scopus (TITLE-ABS-KEY ("pap smear"OR"pap test"OR"papanicolaou test"OR"papanicolaou smear"OR"vaginal smear"OR"cervical cancer screening"OR"cervix cancer screening") AND TITLE-ABS-KEY (Determinant OR Factor OR Barrier OR obstacle OR Facilitator)) AND PUBYEAR > 2017 741
Cochrane "pap smear"OR"Pap test"OR"Papanicolaou test"OR"Papanicolaou smear"OR"Vaginal smear"OR"Cervical cancer screening"OR"Cervix cancer screening"in Title Abstract Keyword AND Determinant OR Factor OR Barrier OR obstacle OR Facilitator in Title Abstract Keyword—with Publication Year from 2018 to 2025, with Cochrane Library publication date Between Jan 2018 and January 2025, in Trials (Word variations have been searched) 25
WOS (TI = (("pap smear"OR"Pap test"OR"Papanicolaou test"OR"Papanicolaou smear"OR"Vaginal smear"OR"Cervical cancer screening"OR"Cervix cancer screening") AND (Determinant OR Factor OR Barrier OR obstacle OR Facilitator)) OR AB = (("pap smear"OR"Pap test"OR"Papanicolaou test"OR"Papanicolaou smear"OR"Vaginal smear"OR"Cervical cancer screening"OR"Cervix cancer screening") AND (Determinant OR Factor OR Barrier OR obstacle OR Facilitator)) Document Types: Article or Proceeding Paper Languages: English Timespan: 2018–01-01 to 2025–01–15 (Publication Date) 266
ProQuest noft("pap smear"OR"Pap test"OR"Papanicolaou test"OR"Papanicolaou smear"OR"Vaginal smear"OR"Cervical cancer screening"OR"Cervix cancer screening") AND noft(Determinant OR Factor OR Barrier OR obstacle OR Facilitator) Additional limits—Date: From January 01 2018 to January 15 2025 320

Eligibility criteria

We included studies that fulfilled the following eligibility criteria: 1) studies of all design types, 2) investigations of determinants, factors, barriers, obstacles, and facilitators affecting pap-smear test uptake among Asian women, 3) written in English, and 4) published between 2018 and 2025. Additionally, we excluded narratives and qualitative investigations.

Study selection

Two researchers independently compared each of the obtained documents with respect to the objective of the current study as well as the inclusion and exclusion criteria. Studies that were not related to the objective and did not meet the entry conditions were removed. Any disagreement between the two researchers regarding the evaluation of the documents was resolved by a third researcher.

Data extraction

From the reviewed studies, information such as the name of the first author, year of publication, country of study, study design, study population, and key results about determinants, factors, barriers, obstacles and facilitators of Pap-smears test uptake among Asian women have been extracted in the form of an Excel checklist.

Literature quality assessment

Two people separately and independently evaluated the quality of the studies. In this way, all the sections of individual study were scored based on the descriptive study checklist of Newcastle–Ottawa Scale, and at the end, the studies that had a score lower than the acceptable threshold have been excluded. The Newcastle–Ottawa Scale (NOS) is utilized to assess the quality of non-randomized studies, particularly cohort and case–control studies, based on three main criteria: selection of study groups, comparability of groups, and outcome assessment. The NOS scores range from 0 to 9 points, with a score of 7 or higher generally considered indicative of good quality. Scores below 7 suggest potential issues with study quality that may affect the reliability of the findings. Typically, a score of 7 to 9 points indicates high quality, 4 to 6 points signifies moderate quality, and 0 to 3 points reflects low quality.

Data analysis process

To conceptualize influential factors, barriers and facilitators of Pap-smear test uptake among Asian women, a theoretical thematic analysis was applied. Thematic analysis is a method of qualitative analysis that identifies the semantic pattern or themes in a qualitative data set [12]. First, researchers familiarized themselves with the data by reading and re-reading it to immerse themselves in the content and note initial observations. Next, they generated initial codes by systematically identifying and coding interesting features of the data using manual methods. Following this, they searched for themes by grouping codes into potential themes based on patterns and relationships. Researchers then reviewed these themes, refining them by checking their accuracy against the dataset to ensure they were distinct and representative. After defining and naming each theme and detailing their significance, they wrote a report that integrated the themes into a coherent narrative, supporting each with evidence from the data, including quotes and examples. To enhance validity and reliability, the three researchers collaboratively reviewed the findings, incorporating feedback to adjust themes or interpretations as necessary. Finally, they prepared the final report, ensuring clarity and coherence while highlighting implications and recommendations based on their findings. Consequently, themes relating to conceptualizations were generated by systematically coding all included articles. After the initial coding, the articles and their associated quotes were reviewed to ensure their adequacy and consistency. In the process of this analysis, three researchers formulated the factors, determinants, barriers and facilitators extracted from the studies separately; the prepared themes were then compared and any disagreements were resolved by reaching consensus.

Ethical approval

This study is a master's thesis that has been done by obtaining the necessary licenses from Qazvin University of Medical Sciences, the Vice Chancellor for Health of Qazvin University of Medical Sciences and Qazvin Health Center (ethics code IR.QUMS.REC.1402.002).

PROSPERO

This systematic review was registered in PROSPERO (ID: CRD42023414592).

Results

Four thousand fifty-seven records were obtained through a search. 1083 records were duplicates and dismissed. The title and abstract of 2974 papers were matched with inclusion and exclusion criteria and incompatibles were removed. The papers that conducted in countries in other continents and different had aims from present study was removed based on title and abstract. 867 less-quality full texts were removed. Finally, 44 documents on the determinants, barriers, and facilitators of Pap-smear uptake were entered into the study and its characteristics reported in Table 2 (Fig. 1).

Table 2.

Data extracted from included studies

Ref First Author Year Country Urben/Rural Population (patient or provider perspective) Study design Sample size Average age
Mean
Average age
SD
Instrument Proportion of women ever screened (%) Analysis Region
[17] Mukta Agarwal 2022 India Urban Highly Educated Women Descriptive study 150 36.9 9.7 Questionnaire _

Descriptive statistics

Chi-square test

South Asia
[18] Jyoshma Preema Dsouza 2020 India Urban women aged 30–59 A qualitative exploratory multi-centric cross-sectional study 45 _ _ Questionnaire & interview _ Content analysis South Asia
[19] Yuvaraj Krishnamoorthy 2021 India Urban & Rural Women aged between 30 and 49 years Descriptive-analytical cross-sectional study 336,777 _ _ Secondary data analysis of National Family Health Survey _ Poisson regression model South Asia
[20] Vasundhara Y. Kulkarni 2022 India Urban & Rural Mumbai police personnel Cross-sectional study 3,017 34.92 7.64 Questionnaire, Standardized intensive training in the Department of Preventive Oncology Clinic 69.95 Univariable logistic regression analysis South Asia
[21] Selvam Mahalakshmi 2020 India Urban Womwn aged 32 to 58 years Descriptive qualitative study 19 _ _ Interview 16.7 Manual descriptive thematic analysis South Asia
[22] Nilima Nilima 2022 India Urban & Rural Women in their reproductive ages, 15–49 years A Generalized Structural Equation Modeling Approach 699,686 25 _ Questionnaire & interview 21 Chi-squared test and ranksum test, Path analysis,structural equation modeling South Asia
[23] Elahe Allahyari 2022 Iran Urban & Rural female employees of governmental agencies of Birjand Descriptive-analytical cross-sectional study 1898 _ _ Questionnaire _ Regression analysis & Artifificial Neural Network (ANNs) West Asia
[24] Towhid Babazadeh 2018 Iran Urban Housewife women in Islamabad Cross-sectional study 280 38.9 6.21 Questionnaire 45.7 One-way ANOVA, independent t-test, Pearson correlation coefficient test, Logistic Regression analysis West Asia
[25] Tayebeh Marashi 2021 Iran Urban Women, health staff, obstetricians, and gynecologists, and the research site was Oshnaviyeh County in northwestern Iran

Qualitative study

Focus group discussions

Interviews

32 38.75 _ Interview 31.25 Qualitative content analysis West Asia
[26] Rahimeh Momeni 2020 Iran Urban Women visiting the health centers Cross-sectional, descriptive, analytical study 202 32.75 6.82 Questionnaire 14.8 Linear regression analysis, logistic regression, and multivariate regression analysis West Asia
[27] Mansoureh Refaei 2018 Iran Urban Women referring to health centers Qualitative study 31 _ _ Semi-structured in-depth interviews & Questionnaire _ Qualitative content analysis West Asia
[28] Johanne Greibe Andersen 2020 Nepal Urban Womens

Qualitative study

Focus group discussions

In-depth interviews

48 39 _ Questionnaire 2.8 in-depth interviews South Asia
[29] Elisabeth Darj 2019 Nepal Rural women were in the age range 25–60 years. Most of them were farmers’ wives and worked in households and in the fields

Qualitative study

Focus group discussions

In-depth interviews

7871 _ _ Questionnaire _ Qualitative manifest content analysis South Asia
[30] Bijaya Ghimire 2020 Nepal Urban Women Attending Tertiary Level Hospital Descriptive-analytical cross-sectional study 220 34.38 9.4 Semi structured interview questionnaire 38.6 Descriptive statistics, chi-square, odds ratio, and binary logistic regression South Asia
[31] Heera KC 2022 Nepal Rural 30–60 years married women in Biratnagar, Morang Cross-sectional study 280 40.2 9.16 Face to face interview using a semi structured questionnaire 30 statistical package for the social science South Asia
[32] Nepal J 2022 Nepal Urban Women of age 30–60 years in Bhaktapur Cross-sectional study 360 40 _ Interview 32.2 Descriptive analysis, Principal Component Analysis, Chi square test, Logistic regression analysis South Asia
[33] Niresh Thapa 2018 Nepal Rural Women living in mid-western rural A hospital-based cross-sectional study 360 30.13 10.4 Interview using a structured questionnaire 13.6 Descriptive statistics, Binary logistic regression analysis, χ2 test South Asia
[34] Sumadi L. Anwar 2018 Indonesia Urban & Rural women aged 40 and older without any history of cancer Descriptive-analytical cross-sectional study 5397 52.9 _ Questionnaire _ Multilevel modelling Southeast Asia
[35] Sumarmi Sumarmi 2021 Indonesia Rural Married women A descriptive cross-sectional study 687 42 8.4 Questionnaire 19 Independent t-tests, simple logistic regressions, and a hierarchical logistic regression Southeast Asia
[36] Chin SS, Jamonek NA 2022 Malaysia Urban Women visiting outpatient clinics Cross-sectional study 452 37.7 11.5 Questionnaire 48.5 Logistic regression analysis Southeast Asia
[37] Yunus NA 2018 Malaysia Urban Women aged 20 to 65 years Cross-sectional study 316 _ _ Questionnaire 41.8 Descriptive statistics and multiple logistic regression Southeast Asia
[38] Seyhan Cankaya 2020 Turkey Urban all ≥ 18 year-old women who were married or living with a partner and presented to the selected health center Descriptive study & Cross-sectional study 294 39.9 10.3 Questionnaire 47.6 Independent samples t-tests, descriptive statistical values, Chi-square test West Asia
[39] Raziye Özdemir 2020 Turkey Urban Women in Safranbolu District of Karabuk aged 30–65 Cross-sectional study 374 _ _ Face-to-face interview using questionnaires 26.2 chi-squared test, binary logistic regression model West Asia
[40] Duygu Ürek 2022 Turkey Urban Women aged 25 and over Cross-sectional study 8606 _ _ Face-to-face interview 35.4 Chi-square test West Asia
[41] Huinan Han 2022 China Rural Women under 35 Years Cross-sectional study 1,949 _ _ Questionnaire _ Binary logistic regression analysis, Chi-square test, Sensitivity analyses Southeast Asia
[42] Wei Lin 2022 China Urban & Rural Women aged 20 to 65 years Cross-sectional study 3,651 40.65 _ Questionnaire 63.9 Descriptive analysis, logistic regression analy Southeast Asia
[43] Huan Yang 2019 China Rural Women in eastern China A qualitative study 21 48.7 6.4 Semi-structured in-depth interviews 52.4 Transcribed verbatim and subjected to thematic analysis Southeast Asia
[44] Shilpa Surendran 2023 Singapore Urban Womwn aged 25–69 years Qualitative study 40 54.5 _ Semi-structured interviews _ A qualitative data analysis Southeast Asia
[45] Celestine Yeo Mun Ting 2018 Singapore Urban Postnatal women of at least 21 years old A descriptive cross-sectional study 268 _ _ Questionnaire _ Logistic regression Southeast Asia
[46] Zhengai Cui 2022 Japan Urban & Rural Japanese Women in Their 20 s and 30 s Cross-sectional study 3249 30.85 _ Internet survey & Questionnaire 39.3 A factor analysis, Cronbach’s alpha coefficient, logistic regression analysis East Asia
[47] Noriyo Kaneko 2018 Japan Urban young unmarried Japanese women Internet-based survey 700 26 _ Internet-based survey _ Univariate analysis, the Pearson’s chi-squared test, Mann–Whitney U test East Asia
[48] Misato Kaso 2019 Japan Urban & Rural women of childrearing age Cross-sectional study 49,217 30.8 _ Questionnaire 39.7 Descriptive statistics, univariable logistic regression analysis East Asia
[49] Suzanne Q. Al-amro 2020 Jordan Urban Married Jordanian women aged 21 to 65 years Cross-sectional study 500 38.64 9.39 Questionnaire 31.2 Descriptive and inferential analyses West Asia
[50] Nasar Alwahaibi 2018 Oman Urban patients who attended Outpatient Gynecology Department, female medical staff and university graduate students Cross-sectional study 494 _ _ Questionnaire & interview _ Bivariate analyses & descriptive statistics West Asia
[51] Wafaa T. Elgzar 2022 Saudi Arabia Urban & Rural Women aged 20 to 60 years Cross-sectional study 1085 37.79 _ Questionnaire _ Descriptive statistics & Ordinal logistic regression West Asia
[52] Samina Hirani 2020 Pakistan Urban Women aged 15 to 50 Cross-sectional study 384 30 7.8 Face to face interviews, Questionnaire _ Qualitative analysis South Asia
[53] Sophaphan Intahphuak 2021 Thailand Rural Lahu hill tribe women Quantitative cross-sectional study 650 42.28 _ Interview _ Descriptive statistics, Chi-square test Southeast Asia
[54] Torgyn Issa 2021 Kazakhstan Urban & Rural women attending gynaecological clinics Cross-sectional survey-based study 1,189 36.5 10 Questionnaire _ Descriptive statistics, chi-square test or Fisher’s exact test, univariate and multivariable logistic regression models, crude odds ratio (COR) and adjusted odds ratio (AOR) Central Asia
[55] Shashi Kala 2022 India Rural Tribal Women in Tea Gardens of Darjeeling aged 30–59 years

qualitative study

Focus group discussions

Iinterviews

49 _ _ An interview guide _ Transcribed texts were translated by a person having workable knowledge South Asia
[56] Jom Phaiphichit 2022 Lao Urban Women aged 25–60 years in Lao People’s Democratic Republic A case–control study 360 42.37 9.4 Interview _ Conditional logistic regression Southeast Asia
[57] Hye Young Shin 2021 Korea Urban Female university students aged 20–29 years Mixed-methods design, a quantitative online, Qualitative method 26 21.92 1.26 Focus group interviews _ Descriptive statistics, conventional content analysis East Asia
[58] Dorothy N.S. Chan 2019 China Urban & Rural South Asian women A cross-sectional, exploratory correlational study 776 37.79 _ A self-administered survey _ Path analysis South Asia
[59] Mansoore Shariati-Sarcheshme 2024 Iran Urban married women aged 18–70 A qualitative content analysis 36 42.8 7.6 semistructured in- depth interviews 66.7 Content analysis West Asia

Fig. 1.

Fig. 1

The PISMA 2020 flow diagram of the literature search

Table 3 highlights barriers to pap smear test uptake in the form 7 dimensions of economic (10 components), social (11 components), awareness (9 components), belief (5 components), psychological (3 components), related to the test and provider (13 components) and life style and health behaviors (4 components). Economic factors such as the high cost of tests, transportation expenses, and low income create significant barriers, making it difficult for women to prioritize screenings. Social factors like low literacy levels, traditional gender roles, and lack of support from family and friends contribute to a culture where women may feel discouraged from seeking preventive care. Additionally, social stigmas surrounding cancer and the testing process can further inhibit participation. Beliefs such as religious views, superstitions, and a fatalistic attitude toward cancer can deter women from pursuing necessary medical interventions. Awareness is also crucial; a lack of knowledge about cervical cancer and the importance of pap smears can lead to underestimating personal risk and the necessity of screenings. Psychological factors like embarrassment, fear, and anxiety about the testing process can prevent women from attending appointments. Finally, logistical issues, such as lack of access to healthcare facilities and busy lifestyles, further complicate efforts to increase screening rates. Together, these factors create a complex barrier to pap-smear uptake.

Table 3.

Barriers to pap smear test uptake

Dimensions Components
Economic

1. Expensive pap smear test

2. Transportation costs

3. Low monthly income

4. High monthly expenses

5. Unemployment

6. Lack of financial independence

7. Lack of insurance

8. Non-coverage of the test by insurance

9. Low wealth index

10. Absence or shortage of government providers

Social

1. Low literacy level

2. Gender roles and duties of women (motherhood, housekeeping, job, etc.)

3. Lack of individual independence

4. Low Women's Empowerment Index (WEI)

5. Lack of family support

6. Lack of support from friends

7. Spouse's dissatisfaction or lack of support

8. Social stigma of cancer

9. Social stigma of doing the test

10. Negative recommendations of the community regarding the test

11. Fear of rejection

Belief

1. Religion

2. Superstitious beliefs

3. Thinking that cancer is destiny

4. Lack of belief in clinical medicine and avoiding it

5. Belief in immunity against diseases

Awareness

1. A person's or spouse's lack of awareness of cervical cancer

2. A person's or spouse's lack of awareness of the use and necessity of the Pap smear test

3. Insufficient knowledge in the field of cervical cancer and screening

4. Lack of knowledge about sexually transmitted diseases

5. Lack of awareness of the symptoms and complications of cancer

6. Underestimating your vulnerability to cancer

7. Underestimating the consequences of cancer

8. Thinking that cervical cancer is incurable

9. Thinking that the cancer treatment process is so long

Psychological

1. Embarrassment

2. Fear and anxiety about the test process and result

3. Negligence

Related to the test and provider

1. Fear and lack of interest in the process of the test

2. Considering the test as a time-consuming process

3. Male provider

4. Fear of pain

5. Fear of hygiene of the test

6. Absence of symptoms and the feeling of not needing a test

7. Lack of trust in the health system

8. Lack of confidence in the effectiveness of the Pap smear test

9. Lack of trust in the skill of doctors and staff

10. Lack of trust in private providers

11. Inappropriate behavior of personnel

12. Unpleasant experience of yourself or others from previous tests

13. Lack of access to health centers or long distances

Life style and health behaviors

1. Neglect of health

2. Few visits to health centers

3. Co-morbidities

4. Being busy

Table 4 outlines facilitators of pap smear test uptake in the form of 5 dimensions of economic (10 components), social (11 components), awareness (11 components), related to the test and provider (17 components), and lifestyle and health behaviors (2 components). Economic factors such as free testing, high income, and insurance coverage can remove financial barriers, encouraging women to seek screenings. Additionally, women's financial independence and access to subsidies enhance their ability to prioritize health. Social factors play a critical role as well, with high literacy levels and strong family and community support fostering an environment that promotes health-seeking behavior. Women's empowerment and positive community recommendations can further motivate individuals to undergo screenings. Awareness is another vital dimension; knowledge about cervical cancer and the importance of pap smears can drive women to act. Understanding the benefits of early detection and the safety of the test is crucial for encouraging participation. Moreover, factors related to the test and provider, such as trust in healthcare providers, confidence in hygiene, and the availability of female providers, can alleviate fears and enhance comfort during the testing process. Finally, lifestyle and health behaviors, including regular health check-ups and a proactive approach to health, are essential for fostering a culture of preventive care. Together, these dimensions create a comprehensive framework that can significantly impact pap-smear uptake among women.

Table 4.

Facilitators of pap smear test uptake

Dimensions Components
Economic

1. Free pap smear test

2. High monthly income

3. Employment

4. Women's financial independence

5. Having insurance

6. Test coverage by insurance

7. High wealth index

8. State provider adequacy

9. Allocation of subsidy to screening

10. National and universal test coverage

Social

1. High level of literacy

2. Gender roles and duties of women (motherhood, housekeeping, job, etc.)

3. Individual independence

4. High Women's Empowerment Index (WEI)

5. Family support

6. Support of friends

7. Spouse support

8. Positive recommendations from the community regarding the test

9. Adherence of the person and those around her to regular examinations and screenings

10. Awareness campaigns and promotion of screening

11. Using the media to promote the test’s acceptance

Awareness

1. AA person's or spouse's awareness of cervical cancer

2. A person's or spouse's awareness of the use and necessity of the Pap smear test

3. Sufficient knowledge in the field of cervical cancer and screening

4. Awareness of sexually transmitted diseases

5. Knowledge of the symptoms and complications of cancer

6. Appropriate assessment of your vulnerability to cancer

7. Appropriate assessment of the consequences of cancer

8. Knowing that the test does not harm the health of the women

9. Awareness of early cancer diagnosis through testing

10. Awareness of the benefits of early cancer detection

11. Using the media to increase awareness and information

Related to the test and provider

1. Speed up the testing process

2. Female provider

3. Confidence in the hygiene of the test

4. Trust in the health system

5. Confidence in the effectiveness of the Pap smear test

6. Trust in the skill of the doctor and staff

7. Trust in private providers

8. Confidence in confidentiality

9. Confidence in privacy during testing

10. Appropriate behavior of personnel

11. Pleasant experience of yourself or others from previous tests

12. Easy access to health centers

13. Providing counseling before screening

14. Providing the possibility of online appointment

15. Sending test reminders to qualified people

16. Changing health policies toward screening and treatment

17. Using tools that facilitate screening

Life style and health behaviors

1. Sufficient attention to health

2. Timely and regular visits to health centers

Table 5 outlines various demographic factors and medical history determinants that significantly influence the uptake of pap-smear tests among women. Age plays a crucial role, as younger women may have lower awareness or perceived need for screenings, while older women are often more proactive due to increased health risks. The age at first sex and age of first pregnancy can also impact screening behavior, with earlier sexual activity potentially prompting earlier engagement in preventive measures. Additionally, the number of children a woman has may correlate with increased health awareness, as those with multiple children often have more frequent interactions with healthcare systems. Marital status or sexual activity can further influence access to healthcare, with married women being more likely to seek screenings. Nationality and ethnicity affect attitudes toward preventive care, while residence status highlights disparities in healthcare access, particularly between urban and rural areas. Medical history determinants, such as menstrual and menopausal status, can also shape screening behaviors, as women with regular cycles or those who are postmenopausal may be more attuned to their reproductive health. Factors like the number of sexual partners, contraceptive use, and history of sexually transmitted diseases may heighten awareness of the importance of regular screenings. Moreover, a history of IUD use, abortion, or cancer in family and friends can motivate individuals to prioritize preventive care. Lifestyle factors, including smoking and physical activity, further contribute to health awareness, with smokers being more likely to seek screenings due to the increased risk of cervical cancer. Understanding how these factors influence pap-smear uptake is essential for developing targeted interventions that enhance awareness and accessibility, ultimately leading to better cervical cancer prevention outcomes among women in various populations.

Table 5.

Demographic factors and medical history determinants affecting Pap smear test uptake

Demographic factors and medical history determinants
Age
Age at first sex
Age of first pregnancy
Number of children
Marital status or sexual activity
Nationality/ethnicity
Residence status
Menstrual status
Menopausal status
Number of sexual partners
Use of contraceptives
History of sexually transmitted diseases
History of IUD use
History of abortion
History of cancer in family or friends
Smoking
Physical activity

Discussion

This study included a systematic review of the barriers, facilitators, and factors affecting Pap smear test uptake. A total of 18 countries were examined. 15 studies from South Asia, 12 studies from West Asia, 11 studies from Southeast Asia, 4 studies from East Asia and one study from Central Asia were reviewed.

There were economic, social, awareness, test and provider characteristics, and lifestyle and health behaviors dimensions in both categories of barriers and facilitators. In addition, two religious and psychological dimensions were included in the barriers category. A total of 55 barrier components and 51 facilitator components were identified. In addition, demographic factors and medical history determinants that had a variable effect on the test uptake were also counted.

Economic dimension

Screening cost is a determining factor in the pap smear test uptake [47, 60]. Therefore, income and employment are influential in the pap smear test uptake [61]. Worrying about the costs of cancer testing and treatment if the result is positive makes women not prioritize screening [43, 61, 62]. Therefore, the implementation of cost-effective programs should be on the agenda. Budget allocation, creation of national cancer screening programs, insurance coverage, allocation of government subsidies for screening, and appropriate use of the capacity of the private sector have a significant effect in persuading women and facilitating screening [27, 49]. In sum up, Financial constraints, such as the direct cost of screening, often deter women, especially those from low-income groups or without health insurance. Limited access to affordable healthcare facilities in rural or underserved areas further compounds the issue, along with opportunity costs like taking time off work or managing transportation expenses. However, initiatives like subsidized programs or free Pap smear campaigns by governments and NGOs can effectively address these challenges. Health insurance coverage that includes cervical cancer screening also encourages higher participation rates. Moreover, community-driven solutions, such as providing transportation vouchers or childcare support, help mitigate economic barriers, making it easier for women to access this crucial preventive healthcare service [59, 63, 64].

Social dimension

High health literacy and self-efficacy lead women to increase their knowledge in the field of cancer and participate more in screening [61, 65]. Lack of husband's consent and lack of support from the family causes women's willingness to take the test to decrease [66, 67]. Meanwhile, the encouragement of the husband and the support of friends and family had a significant effect on increasing the Pap smear test uptake [61]. Men's support in low- and middle-income countries has a greater impact on women's participation in screening [28, 65, 68]. By mobilizing volunteers to promote women's health, as well as employing health workers, we can take steps to empower women and facilitate testing [65]. Cultural norms and societal attitudes toward women's health can discourage women from seeking screening due to stigma or fear of judgment [63]. Similarly, a lack of awareness or misinformation about cervical cancer and the importance of Pap smears can limit participation, particularly in communities with low health literacy. On the other hand, social support from family, peers, or community networks can encourage women to prioritize their health and undergo screening [63]. Educational campaigns and advocacy by trusted figures, such as healthcare providers or community leaders, also help dispel myths and foster a positive attitude toward preventive healthcare. By addressing social barriers and leveraging supportive networks, Pap smear uptake can be significantly improved [69].

Awareness dimension

Studies show that knowledge about cervical cancer and screening in developing countries is insufficient [61, 7072]. Meanwhile, awareness of cancer, prevention, and early diagnosis is very decisive [43]. At the same time, some women are not aware of their cancer risk [61]. Some think cancer is a fatal and incurable disease and consider screening useless [43, 47, 66, 72]. Therefore, a continuous awareness program and educational interventions are necessary [65]. A lack of knowledge about cervical cancer and the importance of early detection often prevents women from seeking screening, particularly in communities with low health literacy [63, 64]. Misconceptions and fears surrounding the procedure, such as concerns about pain or embarrassment, further discourage participation [59]. Conversely, educational initiatives and awareness campaigns can significantly enhance understanding and acceptance of Pap smear tests. When women are informed about the benefits of early detection and the simplicity of the procedure, they are more likely to undergo screening [63]. Additionally, healthcare providers who actively educate and encourage their patients can serve as powerful facilitators [59]. Addressing these awareness-related barriers through targeted education and outreach can lead to improved screening rates and better health outcomes.

Test and provider related dimension

In many conservative societies, traditional gender roles dictate that women may feel uncomfortable discussing reproductive health with male healthcare providers, leading to reluctance in seeking necessary screenings. This discomfort is often compounded by social stigma surrounding cervical cancer, which can be viewed as a taboo topic, resulting in shame or fear of judgment from the community. Asian women usually go for a Pap smear test when cancer symptoms appear [43, 61, 73]. Some believe that this test damages the uterus, it is painful and it is not effective [72]. The Pap smear test process is uncomfortable for most women, especially if the provider is male [61]. The lack of female providers, the long distance to health centers, and the overcrowding of health centers reduce screening participation [61, 74]. Testing in rural areas is less than in cities, which can be due to a lack of access [65]. On the other hand, positive and negative experiences in the process and results of previous tests also play a significant role in seeking screening [61, 66]. The solutions that can be used to facilitate this aspect include: using female health personnel, providing advice before screening by health workers, sending reminders to perform the test and screening at work or place of residence [63, 65]. The availability of well-trained and empathetic healthcare providers who can create a comfortable and supportive environment for patients. The use of advanced, less invasive screening technologies also helps to alleviate fears and improve participation. Furthermore, clear communication from providers about the importance of Pap smears and the procedure itself can build trust and encourage women to undergo screening. Addressing these factors through provider training and patient-centered care can significantly enhance Pap smear uptake [63, 75].

Lifestyle and health behavior dimension

Lifestyle and the amount of busyness due to work or having a child have a significant effect on pap smear test uptake [43, 66]. So that many women avoid the test because it is time-consuming [48]. Women who are of reproductive age or have children are less inclined to visit a doctor [48]. On the other hand, people who have more than one sexual partner or who have received the HPV vaccine are more likely to adhere to regular testing [61]. Lifestyle and health behavior factors play a significant role in influencing the uptake of Pap smear tests, acting as both barriers and facilitators. Unhealthy lifestyle choices, such as smoking and poor diet, are often associated with a lower likelihood of participating in preventive health measures, including cervical cancer screening. Additionally, women who do not prioritize regular health check-ups or lack a proactive approach to their health may be less inclined to undergo Pap smear tests. On the other hand, adopting a health-conscious lifestyle, including regular medical visits and preventive care, facilitates higher screening rates. Women who engage in health-promoting behaviors, such as maintaining a balanced diet, exercising, and avoiding risky habits, are more likely to recognize the importance of early detection and participate in screening programs. Educational interventions that promote healthy behaviors and emphasize the benefits of preventive care can further enhance Pap smear uptake [7577].

Belief dimension

Beliefs have a major impact on determining people's behavior [61]. Beliefs related to health, illness, spirituality, and religion have an impact on people's health decisions [61]. Some people consider themselves immune from cancer due to reasons such as a lack of history of cancer in the family, hygiene, lifestyle, and young age [61, 62, 74]. Sexual taboos about sexually transmitted diseases and genital organs have caused some women not to talk about it even with their husbands [61, 63, 78]. On the other hand, some people, especially the elderly, consider cancer to be a divine test or punishment, which causes them not to undergo screening [61]. The promotion of self-sampling methods may improve participation in screening, especially in rural areas [65, 79]. Negative beliefs, such as the perception that Pap smears are unnecessary without symptoms or the fear that the test might lead to a cancer diagnosis, can deter women from seeking screening. Cultural and religious beliefs may also contribute to hesitancy, particularly in communities where discussing reproductive health is considered taboo. Conversely, positive beliefs, such as understanding the importance of early detection and trusting the healthcare system, can encourage women to undergo screening. Educational interventions that address misconceptions and promote accurate information about the benefits of Pap smears are essential in shifting beliefs and improving participation rates [59, 64, 75].

Psychological dimension

Fear and anxiety are common psychological barriers, with many women worried about potential pain during the procedure or the possibility of a positive diagnosis. Feelings of embarrassment and vulnerability also deter participation, particularly when trust in healthcare providers is lacking. Additionally, previous negative healthcare experiences can create psychological resistance to screening. Shame is one of the most important barriers to Pap smear test uptake. Asian women consider this type of screening a violation of privacy and a cause for embarrassment and anxiety. Some also think that this test will have a negative effect on sexual relations and fertility. Also, fear of examination, fear of test results, and fear of cancer treatment are other psychological barriers.

On the other hand, a sense of empowerment and self-efficacy can serve as strong facilitators, encouraging women to take proactive steps for their health. Psychological support from family, friends, and healthcare professionals further reduces anxiety and fosters positive attitudes toward screening. Interventions such as counseling, patient education, and creating a welcoming clinical environment can address these psychological barriers and significantly enhance Pap smear uptake.

Limitations

In this systematic review several potential biases must be acknowledged. Firstly, publication bias may have influenced the findings, as studies with positive results are more likely to be published, potentially skewing the overall understanding of barriers and facilitators. Additionally, selection bias could arise from the inclusion criteria for studies, as those that are published may not represent the full spectrum of experiences or attitudes regarding pap-smear testing in diverse populations. Moreover, the reliance on self-reported data in many studies may introduce response bias, affecting the accuracy of the reported barriers and facilitators. Lastly, the heterogeneity of the included studies in terms of methodologies, sample sizes, and cultural contexts may limit the generalizability of the findings.

Conclusion

Barriers in the seven categories of economic, social, psychological, awareness, belief, test and provider, lifestyle, and health behavior prevent women from uptaking pap smear tests. On the other hand, there are five facilitator groups for screening, which include economic, social, awareness, test and provider, lifestyle, and health behavior. A combination of these factors, with a strong emphasis on awareness, beliefs, and provider-related aspects, appears to be most effective in influencing Pap smear uptake among Asian women [61, 64, 80].

Enhancing awareness through culturally tailored educational campaigns is essential to inform women about cervical cancer risks and the importance of early detection. Addressing psychological barriers, such as fear and misconceptions, can be achieved through counseling and sharing positive testimonials. Improving provider-related aspects is crucial; training healthcare providers in cultural sensitivity and ensuring the availability of female providers can make women feel more comfortable. Accessibility can be increased by offering mobile screening units, community-based clinics, and subsidized costs to make Pap smears more affordable. Social and cultural influences can also play a pivotal role; engaging community leaders and family members, as well as creating support groups, can encourage women to participate in screening programs. Lastly, promoting preventive health behaviors and integrating regular check-ups into community health initiatives or workplace wellness programs can further facilitate Pap smear uptake. By implementing these strategies, barriers can be reduced, leading to increased participation and better health outcomes.

Supplementary Information

Supplementary Material 1 (11.3KB, xlsx)
Supplementary Material 2 (30.1KB, docx)

Authors’ contributions

OKh contributed to the concept and design of the study. BAh contributed to the analysis and interpretation of the data. AMa and AAl contributed to the critical revision of the article and the writing of the manuscript. All authors have read and approved the final manuscript.

Funding

This research didn't receive any funds.

Data availability

All data included in the systematic review are available in the main manuscript.

Declarations

Ethics approval and consent to participate

This study is a master's thesis that has been done by obtaining the necessary licenses from Qazvin University of Medical Sciences, the Vice Chancellor for Health of Qazvin University of Medical Sciences and Qazvin Health Center (ethics code IR.QUMS.REC.1402.002).

Consent for publication

Non-applicable.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Arbyn M, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191–203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.observatory, G.c., Lyon, France: International Agency for Research on Cancer. Available at:https://gco.iarc.fr/. 2018.
  • 3.Ferrall L, et al. Cervical cancer immunotherapy: facts and hopes. Clin Cancer Res. 2021;27(18):4953–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. [DOI] [PubMed] [Google Scholar]
  • 5.Singh D, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 2023;11(2):e197–206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Organization, W.H., Overcoming barriers to cancer screening in resource-constrained settings: Care4Afrique: a pilot cervical cancer screening programme in three African countries. International Agency for Research on Cancer (IARC) news. Available at: https://www.iarc.who.int/news-events/overcoming-barriers-to-cancer-screening-in-resource-constrained-settings-care4afrique/, 2023.
  • 7.Ferlay J, E.M., Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global Cancer Observatory: Cancer Today. 2024 [cited 2025 2025/03/12]; Available from: https://gco.iarc.who.int/today.
  • 8.organization, W.h. Cancer tomorrow. 2025 [cited 2025 2025/03/12]; Available from: https://gco.iarc.who.int/tomorrow/en/dataviz/tables?cancers=23&populations=904_905_908_909_935_903_900.
  • 9.Organization, W.H., Cancer today. Global Cancer Observatory. Available at: https://gco.iarc.fr/today/data/factsheets/cancers/23-Cervix-uteri-fact-sheet.pdf 2020.
  • 10.MacLaughlin KL, et al. Trends over time in Pap and Pap-HPV cotesting for cervical cancer screening. J Womens Health. 2019;28(2):244–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Organization, W.H., Cervical cancer. Health topics. available at: https://www.who.int/health-topics/cervical-cancer#tab=tab_1, 2023.
  • 12.Castle, P.E., M.H. Einstein, and V.V. Sahasrabuddhe, Cervical cancer prevention and control in women living with human immunodeficiency virus. CA Cancer J Clin, 2021. 71(6):505–526. [DOI] [PMC free article] [PubMed]
  • 13.Bouvard V, et al. The IARC perspective on cervical cancer screening. N Engl J Med. 2021;385(20):1908–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Hu K, et al. Invasive cervical cancer, precancerous lesions, and cervical screening participation among women with mental illness in Sweden: a population-based observational study. The Lancet Public Health. 2023;8(4):e266–75. [DOI] [PubMed] [Google Scholar]
  • 15.Organization, W.H., WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. 2021: World Health Organization. [PubMed]
  • 16.Suk R, et al. Assessment of US preventive services Task force Guideline-Concordant cervical cancer screening rates and reasons for Underscreening by age, race and ethnicity, sexual orientation, rurality, and insurance, 2005 to 2019. JAMA Netw Open. 2022;5(1):e2143582–e2143582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Page, M.J., et al., The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. bmj, 2021. 372:n71. [DOI] [PMC free article] [PubMed]
  • 18.Agarwal M, et al. Attitude and Perceived Barriers Among Highly Educated Women Towards Cervical Cancer Screening by Pap Smear: An Online Survey. Cureus. 2022;14(8): e28641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Dsouza JP, et al. Exploring the barriers to cervical cancer screening through the lens of implementers and beneficiaries of the national screening program: A multi-contextual study. Asian Pac J Cancer Prev. 2020;21(8):2209–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Krishnamoorthy Y, Ganesh K, Sakthivel M. Prevalence and determinants of breast and cervical cancer screening among women aged between 30 and 49 years in India: Secondary data analysis of National Family Health Survey - 4. Indian J Cancer. 2022;59(1):54–64. [DOI] [PubMed] [Google Scholar]
  • 21.Kulkarni VY, et al. Determinants of Compliance for Breast and Cervical Cancers Screening among Female Police Personnel of Mumbai, India-A Cross-Sectional Study. Indian J Med Paediatric Oncol. 2022;43(1):60–7. [Google Scholar]
  • 22.Mahalakshmi S, Suresh S. Barriers to Cancer Screening Uptake in Women: A Qualitative Study from Tamil Nadu. India Asian Pac J Cancer Prev. 2020;21(4):1081–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Nilima N, et al. Cervical Cancer Screening and Associated Barriers among Women in India: A Generalized Structural Equation Modeling Approach. Cancers. 2022;14(13):3076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Allahyari E, Moodi M, Tahergorabi Z. Analysis of Pap Smear Screening Factors using Artifificial Neural Network (ANNs). Biomedicine-Taiwan. 2022;12(2):10–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Babazadeh T, et al. Cognitive determinants of cervical cancer screening behavior among housewife women in Iran: An application of Health Belief Model. Health Care Women Int. 2018;39(5):555–70. [DOI] [PubMed] [Google Scholar]
  • 26.Marashi T, et al. Exploring the barriers to Pap smear test in Iranian women: a qualitative study. BMC Womens Health. 2021;21:1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Momeni R, et al. Determinants factors to Pap smear screening among married women in a city of South Iran: applying the BASNEF model. BMC Womens Health. 2020;20:1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Refaei M, et al. Exploring Effective Contextual Factors for Regular Cervical Cancer Screening in Iranian Women: A Qualitative Study. Asian Pac J Cancer Prev. 2018;19(2):533–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Andersen JG, et al. Barriers and facilitators to cervical cancer screening uptake among women in Nepal - a qualitative study. Women Health. 2020;60(9):963–74. [DOI] [PubMed] [Google Scholar]
  • 30.Darj E, Chalise P, Shakya S. Barriers and facilitators to cervical cancer screening in Nepal: A qualitative study. Sex Reprod Healthc. 2019;20:20–6. [DOI] [PubMed] [Google Scholar]
  • 31.Ghimire B, Pathak P. Determinants of Uptake of Cervical Cancer Screening among Women Attending Tertiary Level Hospital. J Nepal Health Res Counc. 2021;18(4):649–54. [DOI] [PubMed] [Google Scholar]
  • 32.Kc H, et al. Knowledge, Practice and Barriers on Cervical Cancer Screening among Married Women. J Nepal Health Res Counc. 2023;20(3):755–60. [DOI] [PubMed] [Google Scholar]
  • 33.Nepal J, et al. Utilization of Cervical Cancer Screening and Associated Factors among Women in Bhaktapur. Nepal Kathmandu University Med J. 2022;20(79):199–206. [PubMed] [Google Scholar]
  • 34.Thapa, N., et al., Knowledge, attitude, practice and barriers of cervical cancer screening among women living in mid-western rural, Nepal. J Gynecol Oncol, 2018, 29(4):e57. [DOI] [PMC free article] [PubMed]
  • 35.Anwar SL, et al. Determinants of cancer screening awareness and participation among Indonesian women. BMC Cancer. 2018;18(1):208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Sumarmi S, et al. Factors associated with the intention to undergo Pap smear testing in the rural areas of Indonesia: a health belief model. Reprod Health. 2021;18(1):138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Chin SS, et al. Factors influencing pap smear screening uptake among women visiting outpatient clinics in Johor. Malaysian Family Physician. 2022;17(2):46–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Yunus, N.A., H. Mohamed Yusoff, and N. Draman, Non-Adherence to recommended Pap smear screening guidelines and its associated factors among women attending health clinic in Malaysia. Malays Fam Physician, 2018. 13(1): 10–17. [PMC free article] [PubMed]
  • 39.Cankaya S, Yuksel G. Barriers to Women’s Pap Smear Testing and Related Risk Factors in Turkey. Clinical and Experimental Health Sciences. 2020;10(3):203–9. [Google Scholar]
  • 40.Özdemir R, et al. Level and Factors Associated with Participation in Population-Based Cancer Screening in Safranbolu District of Karabuk. Turkey Iran J Public Health. 2020;49(4):663–72. [PMC free article] [PubMed] [Google Scholar]
  • 41.Ürek D, et al. Socio-demographic Factors Associated with Utilization of Breast and Cervical Cancer Screening Methods in Turkey. Turkish J Oncol. 2022;37(1):23–31.
  • 42.Han, H.N., et al., Organized Breast and Cervical Cancer Screening: Attendance and Determinants in Rural China. Int J Environ Res Public Health, 2022. 19(14):8237. [DOI] [PMC free article] [PubMed]
  • 43.Lin, W., et al., Pre-Procedural Anxiety and Associated Factors Among Women Seeking for Cervical Cancer Screening Services in Shenzhen, China: Does Past Screening Experience Matter? Front Oncol, 2022. 12:857138. [DOI] [PMC free article] [PubMed]
  • 44.Yang, H., et al., Barriers to cervical cancer screening among rural women in eastern China: a qualitative study. BMJ Open, 2019. 9(3):e026413. [DOI] [PMC free article] [PubMed]
  • 45.Surendran S, et al. Understanding Barriers and Facilitators of Breast and Cervical Cancer Screening among Singapore Women: A Qualitative Approach. Asian Pac J Cancer Prev. 2023;24(3):889–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Yeo C, et al. Factors affecting Pap smear uptake in a maternity hospital: A descriptive cross-sectional study. J Adv Nurs. 2018;74(11):2533–43. [DOI] [PubMed] [Google Scholar]
  • 47.Cui ZG, et al. Factors Affecting the Cervical Cancer Screening Behaviors of Japanese Women in Their 20s and 30s Using a Health Belief Model: A Cross-Sectional Study. Curr Oncol. 2022;29(9):6287–302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Kaneko N. Factors associated with cervical cancer screening among young unmarried Japanese women: results from an internet-based survey. BMC Womens Health. 2018;18(1):132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Kaso M, Takahashi Y, Nakayama T. Factors related to cervical cancer screening among women of childrearing age: a cross-sectional study of a nationally representative sample in Japan. Int J Clin Oncol. 2019;24(3):313–22. [DOI] [PubMed] [Google Scholar]
  • 50.Al-amro SQ, Gharaibeh MK, Oweis AI. Factors Associated with Cervical Cancer Screening Uptake: Implications for the Health of Women in Jordan. Infect Dis Obstet Gynecol. 2020;2020:9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Alwahaibi N, et al. Factors Influencing Knowledge and Practice Regarding Cervical Cancer and Pap smear Testing among Omani Women. Asian Pac J Cancer Prev. 2018;19(12):3367–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Elgzar WT, et al. Perceptions of barriers to cervical cancer screening among Saudi women: A cross-sectional study. Afr J Reprod Health. 2022;26(7s):33–42. [DOI] [PubMed] [Google Scholar]
  • 53.Hirani S, et al. Knowledge, awareness, and practices of cervical cancer, its risk factors, screening, and prevention among women in Karachi. Pakistan Eur J Cancer Prev. 2021;30(1):97–102. [DOI] [PubMed] [Google Scholar]
  • 54.Intahphuak S, Nambunmee K, Kuipiaphum P. Factors Influence on Pap Test Screening among Lahu Hill Tribe Women in Remote Area Thailand. Asian Pac J Cancer Prev. 2021;22(7):2243–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Issa, T., et al., Factors associated with cervical cancer screening behaviour of women attending gynaecological clinics in Kazakhstan: A cross-sectional study. Women's Health, 2021. 17:17455065211004135. [DOI] [PMC free article] [PubMed]
  • 56.Kala, S., et al., Looking Beyond Knowledge and Accessibility-Exploring Barriers and Facilitators for Cervical Cancer Screening Services among Tribal Women in Tea Gardens of Darjeeling, West Bengal. J Clin Diagnostic Res, 2022. 16(4):LC16-LC20.
  • 57.Phaiphichit, J., et al., Factors associated with cervical cancer screening among women aged 25–60 years in Lao People’s Democratic Republic. PLoS One, 2022. 17(4):e0266592. [DOI] [PMC free article] [PubMed]
  • 58.Hye Young, S., et al., Barriers and strategies for cervical cancer screening: What do female university students know and want? PLoS One, 2021. 16(10):e0257529. [DOI] [PMC free article] [PubMed]
  • 59.Chan DNS, et al. Development of an explanatory model to explore cervical cancer screening behaviour among South Asian women: The influence of multilevel factors. Eur J Oncol Nurs. 2019;40:2–9. [DOI] [PubMed] [Google Scholar]
  • 60.Shariati-Sarcheshme M, et al. Women’s perception of barriers and facilitators of cervical cancer Pap smear screening: a qualitative study. BMJ Open. 2024;14(1): e072954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Afsah YR. Perceived barriers of cervical cancer screening among married women in Minggir, Godean, Gamping Sub-Districts. Sleman District Yogyakarta IJNP (Indonesian Journal of Nursing Practices). 2017;1(2):75–82. [Google Scholar]
  • 62.Salehiniya H, et al. Factors related to cervical cancer screening among Asian women. Eur Rev Med Pharmacol Sci. 2021;25(19):6109–22. [DOI] [PubMed] [Google Scholar]
  • 63.Gu C, et al. Exploring Chinese women’s perception of cervical cancer risk as it impacts screening behavior: A qualitative study. Cancer Nurs. 2017;40(4):E17–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Kirubarajan A, et al. Barriers and facilitators for cervical cancer screening among adolescents and young people: a systematic review. BMC Womens Health. 2021;21(1):122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Al-Oseely SA, Manaf RA, Ismail S. Barriers and Facilitators Factors to Uptake of Cervical Cancer Screening Among Women in Low-and Middle-income Countries: A Narrative Review. Malaysian J Med Health Sci. 2023;19(4):354–9. [Google Scholar]
  • 66.Shrestha AD, et al. Cervical cancer screening utilization, and associated factors, in Nepal: a systematic review and meta-analysis. Public Health. 2022;210:16–25. [DOI] [PubMed] [Google Scholar]
  • 67.Hassani L, et al. Barriers to pap smear test for the second time in women referring to health care centers in the South of Tehran: A qualitative approach. Int J Comm Based Nurs Midwifery. 2017;5(4):376–85. [PMC free article] [PubMed] [Google Scholar]
  • 68.Feriyawati L, et al. Knowledge of cervical cancer, attitude and husband’s support of Pap smear among multiparous women which have Pap’s smear examination in Aviati clinic Padang Bulan Medan. In: IOP Conference Series: Earth and Environmental Science. Bristol: IOP Publishing; 2018.
  • 69.Ebu NI, et al. Impact of health education intervention on knowledge and perception of cervical cancer and screening for women in Ghana. BMC Public Health. 2019;19(1):1505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Prowse SR, Brazzelli M, Treweek S. What factors influence the uptake of bowel, breast and cervical cancer screening? An overview of international research. Eur J Pub Health. 2024;34(4):818–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Abulizi G, et al. Knowledge of cervical cancer and Pap smear among Uyghur women from Xinjiang. China BMC women’s health. 2018;18(1):1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Amin R, et al. Disparities in cervical cancer screening participation in Iran: a cross-sectional analysis of the 2016 nationwide STEPS survey. BMC Public Health. 2020;20(1):1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Miri, M.R., et al., Cognitive predictors of cervical cancer screening's stages of change among sample of Iranian women health volunteers: A path analysis. Plos One, 2018. 13(3):e0193638. [DOI] [PMC free article] [PubMed]
  • 74.Dhaher EA. Knowledge, attitudes and practices of women in the southern region of Saudi Arabia regarding cervical cancer and the pap smear test. Asian Pac J Cancer Prev. 2019;20(4):1177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Refaei M, et al. Cervical cancer screening in Iranian women: Healthcare practitioner perceptions and views. Asian Pac J Cancer Prev. 2017;18(2):357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Safitri A, Demartoto A, Prasetya H. Meta-Analysis: Factors Related to Pap Smear Service Utilization Using Health Belief Model. J Health Promo Behav. 2024;9(1):14–27. [Google Scholar]
  • 77.Aldohaian AI, Alshammari SA, Arafah DM. Using the health belief model to assess beliefs and behaviors regarding cervical cancer screening among Saudi women: a cross-sectional observational study. BMC Womens Health. 2019;19(1):1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Purnamasari E, Demartoto A, Budihastuti UR. Application of Theory of Planned Behavior on Factors Associated with Pap Smear Uptake: A Meta-Analysis. Journal of Health Promotion and Behavior. 2024;9(2):102–18. [Google Scholar]
  • 79.Bayrami R, Taghipour A, Ebrahimipour H. Personal and socio-cultural barriers to cervical cancer screening in Iran, patient and provider perceptions: a qualitative study. Asian Pac J Cancer Prev. 2015;16(9):3729–34. [DOI] [PubMed] [Google Scholar]
  • 80.Kamath Mulki, A. and M. Withers, Human Papilloma Virus self-sampling performance in low-and middle-income countries. BMC Womens Health, 2021. 21: 1–11. [DOI] [PMC free article] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Material 1 (11.3KB, xlsx)
Supplementary Material 2 (30.1KB, docx)

Data Availability Statement

All data included in the systematic review are available in the main manuscript.


Articles from BMC Public Health are provided here courtesy of BMC

RESOURCES